Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

469
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
469
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

567
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
567
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

180
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
180
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

519
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
519
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

769
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
769

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders.

Seminars in neurology·2022
Same author

Tales of a department: how the COVID-19 pandemic transformed Detroit's Henry Ford Hospital, Department of Neurology-part I: the surge.

BMJ neurology open·2021
Same author

Myasthenia gravis and pregnancy.

Muscle & nerve·2020
Same author

Value of terminal latency index and sensory electrophysiology in idiopathic and diabetic chronic inflammatory demyelinating polyradiculoneuropathy.

Clinical neurophysiology practice·2019
Same author

Suprascapular neuropathy: A review of 87 cases.

Muscle & nerve·2019
Same author

Oculopalatal tremor, facial myokymia and truncal ataxia in a patient with neurosarcoidosis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2014

Related Experiment Video

Updated: Jan 9, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.8K

Rhabdomyolysis.

Kavita M Grover1,2, Naganand Sripathi1,2

  • 1Department of Neurology, Henry Ford Health, Detroit, Michigan, USA.

Muscle & Nerve
|December 10, 2025
PubMed
Summary

Rhabdomyolysis, a condition of severe muscle injury indicated by high creatine kinase levels, can stem from trauma, medications, or various disorders. Prompt identification of triggers and appropriate treatment, including fluid therapy and metabolic correction, are crucial for managing this condition.

Keywords:
creatine kinase (CK)muscle damagemyoglobinuriamyonecrosisrhabdomyolysis

More Related Videos

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

2.9K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

12.0K

Related Experiment Videos

Last Updated: Jan 9, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.8K
Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

2.9K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

12.0K

Area of Science:

  • Biochemistry
  • Pathology
  • Internal Medicine

Background:

  • Rhabdomyolysis is defined by significant muscle damage and elevated creatine kinase levels.
  • Muscle injury can arise from diverse causes including trauma, medications, toxins, and underlying health conditions.
  • A thorough patient history is essential for pinpointing the root cause of rhabdomyolysis.

Purpose of the Study:

  • To review the etiology, diagnosis, and management of rhabdomyolysis.
  • To emphasize the importance of identifying and removing inciting factors.
  • To outline current treatment strategies for rhabdomyolysis and its complications.

Main Methods:

  • Literature review of rhabdomyolysis causes and treatments.
  • Analysis of diagnostic approaches including historical review.
  • Evaluation of therapeutic interventions such as fluid resuscitation and metabolic correction.

Main Results:

  • Rhabdomyolysis etiology is multifactorial, including trauma, drugs, and genetic predispositions.
  • Early identification and removal of causative agents are critical.
  • Aggressive fluid therapy, metabolic correction, and renal support are key treatment components.

Conclusions:

  • Prompt diagnosis and management are vital for improving outcomes in rhabdomyolysis.
  • Addressing the underlying cause and initiating supportive care can prevent severe complications.
  • Rhabdomyolysis requires a comprehensive approach involving trigger identification and targeted medical interventions.